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EXECUTIVE SUMMARY 
 
 
Introduction 
 
This report is an evaluation of Flora Fit Street (FFS) based in Clapham Park London.  FFS was 
launched in June 2004 as a 12 month public private partnership between Flora and Clapham Park New 
Deal for Communities (NDC). Its purpose was to improve the local community’s heart health by 
providing a whole range of activities, information and events that focused on increasing physical 
activity, improving nutrition and smoking cessation. Recruitment into FFS took place through ‘Healthy 
Heart MOTs’. These events took place throughout the year and were widely advertised throughout the 
community.  Residents could come for a health check-up, which included a 20 minute consultation 
with a health consultant and optional consultations with fitness and nutrition experts.  Over the 12 
weeks following the MOT the participants had full access to the whole range of Flora Fit Street 
activities.  At the end of that time, participants were asked to return for a 12 week exit MOT.  
Participants in the research study were then invited to attend a follow-up consultation 3 months after 
the end of the intervention.   
 
 
Methods and Design 
 
Recruitment into the study took place over the final two ‘Healthy Heart MOT’ events in February 2005.  
During their initial consultation, eligible residents were asked if they would like to consent to take part 
in the study. For those who consented, the data gathered as part of their participation in FFS was 
made available to the research team, and they were followed up at six months after entry to FFS.  
The data included a lifestyle questionnaire and range of physiological measures, the outcome 
measures included were: 
 
• Cholesterol (primary outcome measure). 
• Blood Glucose. 
• Blood pressure. 
• Resting heart rate. 
• Body mass index. 
• Energy expenditure using the ‘Seven Day Activity Recall’ (McArdle et al. 1985). 
• Self-perceived health, using the SF-36 (Ware and Sherbourne 1992). 
• Current physical activity status using a version of the ‘Stages of Change’ (Prochaska 1979). 
 
 
Findings 
 
Baseline Sample - Demographics 
 
• 199 participants consented to take part in the study.  There were a larger number of women 
(n=126) than men (n=73). 
 
• A statistically significant difference (p=0.007) is found between the age distribution of 
participants in the study sample and the age distribution expected for the Clapham Park NDC 
area (Census, 2001).  In the baseline sample the age groups 30-44 and 45-59 are over 
represented and the age group 65+ is under represented. 
 
• No significant difference (p=0.06) is found between the ethnic distribution of the study 
sample and what might be expected for Clapham Park NDC (Census, 2001). 
 
• A statistically significant difference (p=0.02) is found between the ethnicity of male and 
female study participants.  Male participants were predominately white. 
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Baseline Sample – Health Status 
 
• 32.5 % of the participants had a cholesterol level over 5.0 mmol/L.   
 
• Statistically significant differences were found in the percentage of participants having 
desirable cholesterol levels by age group (p<0.001) and by gender (p=0.028).  Higher 
percentages of participants having undesirable levels of cholesterol were found for men and 
for older age groups.  
 
• 60.3% of the participants were either overweight or obese having a BMI of 25 or over.  The 
mean BMI for males and females was higher than the national average. 
 
• The number of smokers in the baseline sample (26.5%) was about the same as the national 
average (26%)  However, the percentage of male smokers (31.5%) in the sample was higher 
than the national average (27%) and the percentage of female smokers (22.2%) was lower 
than the national average (25%). 
 
 
Comparing baseline characteristics for those who returned and those who dropped out 
 
• 111 participants returned for their 12 week exit MOT.  Return rates were higher for women 
than men, the difference is statistically significant (p=0.022). 
 
• 35 participants returned for their 6 month follow-up consultation.  Return rates for women 
were no longer significantly higher than for men. But, return rates were significantly higher 
for older participants (p=0.017), suggesting that FFS was better at retaining older people. 
 
• In all other respects, at both time points, those who returned for the follow-up did not differ 
from those who did not return (drop outs) in respect of other demographic characteristics 
(ethnicity) or in terms of baseline health-related variables (weight, BMI, blood pressure, 
physical activity status, stage of change, and smoking status). 
 
 
Health Status changes between baseline and the 12 week exit MOT 
 
• Firstly, in the major outcome variable, cholesterol, a statistically significant change was found.  
There was a 14.5% increase in the number of people who attained a desirable cholesterol 
level of 5 mmol/L or below.  Only 3 participants who had a cholesterol level of 5 mmol/L or 
below at baseline increased, while 18 participants whose cholesterol levels were over 5 
mmol/L decreased into the desirable range, this was a statistically significant change 
(p=0.001). The mean cholesterol level decreased by 0.28 mmol/L; this decrease is statistically 
significant.  This represents a 5.9% reduction in the mean cholesterol level over 12 weeks.   
 
• There was an 11.9% increase in the number of people who attained a glucose level of 
6mmol/L or below.  This was a statistically significant change (p=0.041) with 24 participants 
who had a glucose level of over 6mmol/L at baseline decreasing to a desirable level.  The 
mean glucose level decreased by 0.30 mmol/L; this decrease is statistically significant.  This is 
a 5.7% reduction in the mean glucose level over 12 weeks.   
 
• An analysis of the SF-36 found that there was a statistically significant change, in the direction 
of improved health, on 2 of the 8 dimensions; ‘bodily pain’ (p=0.017) and ‘general health 
perception’ (p<0.001). 
 
• Statistically significant changes were found in the food choices people were reporting.  The 
number of healthy food choices increased (p=0.003) for 44.7% of the participants and the 
number of non-healthy food choices decreased (p<0.001) for 40.6% of the participants. 
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• No other statistically significant changes were found for the 12 week exit MOTs.  A high level 
of missing data in the 12 week follow-up sample for the ‘7-day activity recall’ meant data was 
only available for 60 participants, this small sample size may account of the lack of change 
found. 
 
 
Health Status changes between baseline and 6 month follow-up 
 
• Firstly, in the major outcome variable, cholesterol, a statistically significant change was found.  
There was a 25.8% increase in the number of people who attained a desirable cholesterol 
level of 5mmol/L or below.  Only 4 participants who had a cholesterol level of 5 mmol/L or 
below at baseline increased, while 13 participants whose cholesterol levels were over 5 
mmol/L decreased into the desirable range, this was a statistically significant change 
(p=0.012). The mean cholesterol level decreased by 0.634 mmol/L; this decrease is 
statistically significant.  This represents a 13.2% reduction in the mean cholesterol level over 
6 months. 
 
• For the 28 participants who had attended all three sessions, the mean cholesterol level 
decreased by 0.67 mmol/L. This represents a 13.9% reduction in their mean cholesterol level 
over 6 months. 
 
• There were no statistically significant changes in the participant’s glucose levels. 
 
• An analysis of the SF-36 found a statistically significant change, in the direction of improved 
health, on 1 of the 8 dimensions, ‘Role limitation due to physical problems’ (p=0.030). 
 
• A statistically significant change was found in the number of non-healthy food choices 
reported (p=0.002), with 43% of participants reporting a decrease in the number of non-
healthy food choices.  There was a 52% increase in the number of people reporting an 
increase in healthy food choices however, this does not represent a significant change 
(p=0.230). 
 
• A statistically significant improvement (p=0.007) was found in the ‘Stage of Change’ outcome 
variable with 52% of participants making positive changes in their behaviour and motivation 
towards taking part in physical activity. 
 
• No other statistically significant changes were found for 6 month follow-up.  However, the 
small sample size may account for the lack of other changes found. 
 
 
Implications 
 
Overall, for the participants who stayed with the program, these findings suggest that FFS has had a 
positive and sustained effect on their health. Most significantly, FFS had a significant and lasting effect 
on the participant’s cholesterol levels. It has been shown that a sustained 1% decrease in blood total 
cholesterol produces about a 2-3% decrease in the risk of developing CHD (Tang et al. 1998).  So, the 
13.2% decrease in cholesterol could be said to translate into an overall decrease in the risk of 
participants developing CHD of between 26.4% and 39.6%. If this success can be replicated, then the 
public health implications for a community seem to be noteworthy.  An initiative like Flora Fit Street 
can thus provide a useful template as the government seeks to meet its community health targets. 
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1.0 INTRODUCTION 
 
 
1.1 Background 
 
Flora Fit Street (FFS) was a community based heart-health intervention, formed out of a public-private 
partnership between Flora and Clapham Park NDC1.  Clapham Park has a population of just over 7000 
and is classed as one of the UK’s most deprived estates; it is located in London Borough of Lambeth. 
It is estimated that the number of age-standardised deaths (under 65 year olds) in Lambeth is 14.8% 
higher for men and 5.8% higher for women than the national average (Petersen et al. 2005).  
 
Launched in June 2004 and lasting for 12 months, the project’s aim was to improve the community’s 
heart health by seeking to provide the local residents with the information and facilities needed to 
adopt a healthier lifestyle. This consisted of a whole range of activities, information and events based 
around increasing physical activity, improving nutrition and smoking cessation.  These events sought 
to include something suitable for everybody at no, or subsidised, cost and within easy access.  
 
 
1.2 The health context 
 
Coronary heart disease is the single largest cause of mortality in the UK, with around one in five men 
and one in six women dying from the disease every year (Petersen et al. 2005).  While the risk of 
developing CHD can be genetic and increase with age, it is also well established that the single 
greatest modifiable risk factor that can contribute to its development is elevated levels of total and 
LDL cholesterol (Grundy 1999).  Within the UK, 66% of adults over 16 have a blood cholesterol of 5.0 
mmol/L or above (Petersen et al. 2005), the target level set in the National Service Framework for 
CHD.  Recent research has suggested that if the UK risk factors, cholesterol combined with smoking, 
could be lowered to equal that of the US or Scandinavia, the amount of deaths from CHD could be 
halved (Unal et al. 2005). It is estimated that smoking causes around 30,600 (18.5%) of CHD related 
deaths in the UK (Petersen et al. 2005). 
 
The cost of food related ill health to the NHS is calculated to be more than double that of smoking; 
one recent study estimated the cost to be around 6 billion annually (Rayner and Scarborough, 2005).  
In the UK as a whole, salt and saturated fat intake is too high and obesity levels continue to rise; the 
rate of obesity among the 16-64 year olds now over 50% higher than a decade ago (DOH, 2004a).  
This rise, of course, is also linked to physical inactivity.    
 
Regular physical activity significantly decreases the risk of developing CHD (Petersen et al. 2005, DOH 
2004b).  Levels of physical activity are in overall decline, with only 37% of men and 24% of women 
meeting recommended daily guidelines.  In trying to rectify this, the government, in its recent white 
paper ‘Choosing health’ (2004a), set out some ambitious targets.  It aims to increase the percentage 
of individuals doing 30 minutes of physical activity five days a week to 50% by the year 2011, and to 
70% by the year 2020.  
 
Demographic and socio-economic factors also play a significant part.  Premature death rates caused 
by CHD are over 50% higher in manual workers than non-manual (Petersen et al. 2005), poor diets 
are significantly more prevalent in men, young people and lower socio-economic groups (Kearney et 
al., 2005) and it has also been found that it is less likely that people from less advantageous social 
and economic situations will change to a healthier lifestyle (Boniface et al. 2001).  
 
 
                                                 
1 The New Deal for Communities is a government strategy aimed at regenerating the country's most deprived 
neighbourhoods.  £2bn has been committed to 39 NDC areas with these communities having around £50m each 
to invest over a 10-year period.   
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1.3 The theoretical context 
 
Labonte defined community-based interventions as, “the process of health professionals and/or health 
agencies defining the health problem, developing strategies to remedy the problem, involving local 
community members and groups to assist in implementing strategies to resolve the problem” 
(Dobbins and Beyers 1999: 14) . Over the past 20 years the evidence relating to the effectiveness of 
community based health interventions has been mixed. Early large-scale interventions proved 
promising, the 1989 Stanford Five City Project (an American community-based heart health 
programme) was one such example that seemed to set a benchmark other such initiatives have failed 
to reproduce (Verheijden and Fok 2005). This project used a social marketing approach which 
attempts to “influence the voluntary behaviour of members of the target market by offering benefits 
and reducing barriers for the desired behaviour” (Verheijden and Fok 2005: 67).  It saw reductions in 
participants’ smoking habits as well as other positive health related outcomes, a lowering of blood 
pressure, cholesterol and a slight increase in physical activity (Farquhar et al. 1990)   
 
Similar large-scale community heart-health programmes since seemed to have had little or no effect 
on physical activity, smoking behaviour, blood pressure, blood cholesterol or weight loss, although 
some more positive effects were seen on dietary habits and behaviours (Verheijden and Fok 2005, 
Dobbins and Beyers 1999).  It was also found that these programmes quickly lost their initial 
effectiveness unless they were continually presented as new or exciting (Dobbins and Beyers 1999).     
 
However, it seems that similar health interventions that have targeted specific neighbourhoods and/or 
high risk groups within a population consistently shown greater effects (Butriss et al. 2004, Verheijden 
and Fok 2005, Dobbins and Byers 1999).  Moreover, in terms of programmes specifically related to 
increasing physical activity, a recent review found that interventions in community settings that 
targeted individuals “are effective in producing short-term changes in physical activity, and are likely 
to be effective in producing mid-to long-term changes” (Hilsdon et al. 2005: 11).  These interventions 
incorporated three crucial factors.  Firstly, their theoretical basis was related to behaviour change and 
tailoring advice to individual needs.  Secondly, they promoted physical activity of a moderate intensity 
that was not dependent on facilities, and finally, the individual’s contact with exercise specialists was 
ongoing (Hilsdon et al. 2005).  However, there are still large gaps in the evidence base (Hilsdon et al. 
2005, Wanless 2004, Blamey and Mutrie 2003) that relate to the most appropriate settings for these 
interventions, the ideal time-scale, and the amount of contact time to assure the best possible results 
(Blamey and Mutrie 2003).  
 
Similarly, while there have been far fewer community interventions in the UK based on affecting 
dietary change, the most effective seem to have been those that provided some sort of tailored advice 
or individual counselling (Butriss et al. 2004, Steptoe et al. 2005, John and Ziebland 2004). This also 
seems to be backed up by evidence from other western countries that found health interventions 
promoting dietary change, in a similar way, albeit different contexts, are proven to be effective 
(Ammerman 2002, Burke 2005, Delichatsios 2001, Pignone et al. 2003). Correspondingly, research 
into the effectiveness of smoking-cessation interventions has shown that high intensity interventions 
and interventions delivered by healthcare professionals offering tailored advice are effective (Pisinger 
2005, Mojica et al. 2004, Lancaster et al. 2000, EPHPP 2001). 
 
Successful elements from previous interventions were combined in the construction of FFS. It targeted 
a specific neighbourhood contained within a defined geographical area. Like Stanford, it used a social 
marketing approach.  The intervention was based on a behaviour change model, offering several 
opportunities for individuals to have individualised counselling and follow-up from specialists. It also 
used the expertise of a PR company, which promoted its heart-health programme to the community 
as fresh and exciting through a very high profile campaign that included TV coverage, a website and a 
wide range of user friendly information and literature.  
 
1.4 Objectives 
 
While there is almost universal consensus amongst health experts that a healthy lifestyle promotes 
heart health, there remains a lack of robust evidence-based research into the effect of programmes 
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aiming to achieve such lifestyle changes (Wanless 2004).  The purpose of this evaluation is to add to 
the evidence base in the following ways: 
• To evaluate the effects of Flora Fit Street on health-related factors. 
• To measure the reduction of the modifiable risk factors for CHD following the lifestyle 
intervention. 
• To measure changes in attitudes to making lifestyle changes. 
• To contribute to the evidence base for the development of future primary prevention and 
community intervention programmes. 
 
 
1.5 The intervention 
 
FFS, in conjunction with locally based dietitians, fitness professionals and health service providers 
organised a wide range of health and fitness based activities in the Clapham Park area (see appendix 
II).  This included regularly holding health promotion events that offered participants the opportunity 
to have a ‘Healthy Heart MOT’ at a local school or community centre.  These were held during the 
week and at weekends with varied opening times making them accessible to as many people as 
possible. 
 
These events were widely advertised in the community, each house was leafleted, as well as local 
shopping centres; adverts were also placed in the local newspapers.  On arrival for a ‘Healthy Heart 
MOT’, participants were asked to self-complete a lifestyle and health questionnaire, which included a 
number of validated instruments (see section 2)’ assistance was offered to any people who needed it.  
Arrangements had been made for interpreters to be called on should the need arise, this was not 
found necessary, family members assisted with language in some cases.  The questionnaire was then 
used as a basis for a consultation with a Health Consultant, who, following a motivational change 
model, gave participants information and lifestyle advice covering diet, physical activity and smoking 
cessation. Participants were then offered individual 20-minute consultations with a registered Dietician 
and fitness professional.  During the following 12 weeks the participants had access to the full 
programme of health and physical fitness activities provided by the Flora Fit Street programme in the 
Clapham Park area (see appendix II).  At the end of 12 weeks participants were offered an exit 
‘Healthy Heart MOT’ where they were retested and given information on the progress they had made.  
All the participants who had consented into the research study were then invited to attend a follow-up 
consultation 3 months after the end of the intervention which repeated the same measures and 
questionnaires. This was to monitor the longer term effects of the intervention. 
 
 
1.6 Recruitment into the study 
 
Participants for the scientific study were recruited in the last 4 months of the Flora Fit Street Project 
during two ‘Healthy Heart MOT’ events.  If a participant met the criteria for taking part in the study 
(see Appendix I), the health consultant during their initial consultation, would explain the purpose of 
the study and offer people the chance to take part. Those agreeing to participate were given further 
written information, the opportunity to ask questions and a consent form to sign. The GPs of all 
participants were informed that their patients were taking part in the study.  A further letter was sent 
to the GPs of those participants whose baseline measurements exceeded the agreed referral levels 
(see appendix III).  All participants were informed that they were free to withdraw from the study at 
any stage without further obligation. 
 
Participants were recruited into the study over the course of two Healthy Heart MOT events.  120 
participants consented to take part in the study at the first event, which was held over between 
Thursday the 3rd and Sunday 6th of February.  A further 80 people consented at the second event 
which took place between Thursday 24th and Saturday 26th of February. The 12 week follow-up events 
took place between Thursday 12th and 14th of May and Friday 20th and 22nd of May. Participants who 
did not return were followed up by local community nurses during the month of June. 
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The data for the final follow-up consultation was collected between September and November 2005 
by local community nurses.  All the baseline participants were contacted by telephone and invited to 
attend the consultation at a local health centre at a mutually convenient time.  
 
 
1.7 Ethics and Research Governance Clearance 
 
Ethics approval was given by the St Thomas’ Hospital Research Ethics Committee, reference 
04/Q0702/141 - 13 January 2005.   
 
Research governance clearance was given by the Research Support Unit based at Southwark PCT.  
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2.0 EVALUATION DESIGN 
 
The evaluation was carried out using an uncontrolled before and after design.  Measurements were 
made at baseline (entry into the Flora Fit Street Programme), 12 weeks after entry and to asses 
longer-term effects, a follow-up assessment was carried out six months after entry, i.e. 3 months after 
the end of the intervention.  
 
The main quantitative measures used for the evaluation and analysed in the findings are as follows: 
 
• Cholesterol (primary outcome measure) (fingerprick measured via Roche Accutrend 
GC Machine) 
 
• Blood Glucose (random fingerprick, as per cholesterol) 
 
• Blood Pressure (in triplicate) 
 
• Body Mass Index 
 
• Smoking 
 
• Waist Measurement  
 
• Resting Heart Rate 
 
• Total amount of energy expended (kcal) per week, calculated from the ‘Seven Day 
Activity Recall’ (McArdle et al. 1985), a self-report measure that examines how much 
physical activity is undertaken in a typical week. 
 
• Self-perceived health, using the SF-36 (Ware 1992). This gives scores on 8 different 
dimensions: physical functioning; role limitations due to physical problems; pain; social 
functioning; mental health; role limitations due to emotional problems; vitality/energy; 
general health perceptions.  
 
• current physical activity status, using a version of the ‘Stages of Change’, (Prochaska 
1979) 
 
For a more a detailed explanation of the Visit schedule see Appendix III and the final three measures 
above see Appendix IV. 
 
 
2. 1 Statistical Analysis 
 
Data was entered into SPSS (version 10).  Prior to commencement of analysis, data entry was 
checked through the application of several different procedures.  Two-tailed tests with a significance 
level of 0.05 have been used throughout the report.  Two-sample t-tests were used to compare 
means for different groups of participants at each stage of the study.  A McNemar test was used for 
paired comparison of binary variables such as comparing baseline and 12 week smoking status.  
Association between categorical variables was tested with a chi-squared test.  A Wilcoxon signed rank 
test was used if the data was taken from a distribution that did not show normality.  95% confidence 
intervals are presented throughout the report. 
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3.0 BASELINE DEMOGRAPHICS 
 
This section describes the demographic characteristics of the study sample at baseline, in terms of 
gender, age and ethnicity.  It should be noted that no information was collected on occupation or on 
any measures of social class. 
 
3.1 Gender 
 
199 people consented to take part in the study, as Table 1 shows, the majority were female (63.3%). 
 
Table 1: Participants by gender 
 No. of Participants Percentage of Participants 
Male 73 36.7 
Female 126 63.3 
Total 199 100.0 
 
3.2 Age 
 
Table 2 illustrates the age distribution of participants and compares it to the population of Clapham 
Park NDC (Census 2001) as a whole.  Using a chi squared goodness of fit test a statistically significant 
difference was found between the age distribution in the study sample and the age distribution of 
Clapham Park NDC (X2=16.02, df = 5, p=0.007). It can be seen that the age groups 30-44 and 45-59 
are over represented, by 4.9% and 5.7% respectively.  There is a slight under representation of  
-2.8% in the 25-29 age group, and a larger under representation of -7.7% in the 65+ age group.  
 
Table 2: Percentage of study participants by age - comparison to Clapham Park NDC 
 % study % Clapham 
Park NDC 
Difference  
(% study - % CP NDC) 
18-24 14.1 14.3 -0.2 
25-29 14.1 16.9 -2.8 
30-44 42.7 37.8 4.9 
45-59 21.6 15.9 5.7 
60-64 3.5 3.6 -0.1 
65+ 4.0 11.5 -7.7 
Total 100 100  
 
There was no upper age limit for the study, so the percentages shown in Table 2 for Clapham Park 
NDC included all the population 18 and over.  In practice, it is unlikely that people in their 80s and 90s 
would consider joining the project. In fact, there was only one participant over the age of 70. If we 
consider the upper age group more realistically as 65-74 we find there is no significant difference 
between the age distribution of the study population and that of Clapham Park NDC (X2=7.45, df=5, 
p=0.19). 
 
Figure 1 shows the percentage of males and females in each of the different age groups.  It can be 
seen that there is larger percentage of women in each category except the 45-59 age group (27.4% 
male, 18.3 % female) and the 65+ age groups (5.5% male, 3.2% female). 
 
  7
Figure 1: Baseline sample - percentage of participants by age for each gender 
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3.3 Ethnicity 
 
Figure 2 illustrates the overall ethnicity of the study participants.  Table 3 shows how this breakdown 
compares to the population as a whole in Clapham Park NDC (Census, 2001).  Overall, the ethnic mix 
of the study population is a close approximation to the ethnic mix of the population of Clapham Park 
NDC. 
 
 
Figure 2: Baseline sample - percentage of participants by ethnicity 
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Table 3: Baseline sample - participants by ethnicity - comparison to Clapham Park NDC 
 Study sample Clapham Park 
NDC % 
 Number % % 
Difference in 
Percentage 
White British 72 38.9 42 -3.1 
White Irish 3 1.6 3.3 -1.7 
White Other 18 9.72 11.0 -1.28 
White/Black Caribbean 3 1.6 2.0 -0.4 
White/Black African 3 1.6 1.0 +0.6 
White/Asian 3 1.6 0.8 +0.8 
Other Mixed 2 1.1 1.4 -0.3 
Indian 8 4.3 1.8 +2.5 
Pakistani 2 1.1 1.7 -0.6 
Bangladeshi 3 1.6 0.9 +0.7 
Black Caribbean 34 18.4 13.7 +4.7 
Black African 20 10.8 15.8 -5 
Other Black 6 3.2 2.1 +1.1 
Chinese 3 1.6 1.1 +0.5 
Other 5 2.7 0.7 +2.0 
Total 185 100 100  
(Ethnicity is available for 185 of the 199 participants) 
 
Due to the small numbers represented in some of the ethnic groups, these groups were combined into 
five groups (White, Black, Mixed, Asian and other) before a chi squared goodness of fit test was used 
to see if there was a statistically significant difference between the ethnic breakdown of the study 
sample and what might be expected in Clapham Park NDC, no such difference was found (X2 = 9.05, 
df=4, p=0.06). 
 
Figure 3 and Table 4 illustrate that there is a statistically significant difference between the ethnicity of 
male and female study participants (X2 = 12.14, df= 2, p=0.002), with a higher proportion of Black 
females (41.7%) than of Black males (17.1%).  Male participants were predominately White. 
 
Table 4: Baseline sample - participants by gender and ethnicity 
  White Black Other Total 
Male No. 44 12 14 70 
 % 62.9 17.1 20 100 
Female No. 49 48 18 115 
 % 42.6 41.7 15.7 100 
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Figure 3: Baseline sample - participants by ethnicity for each gender 
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4.0 BASELINE HEALTH STATUS 
 
4.1 Cholesterol 
 
The mean cholesterol level for the baseline sample was 4.67 mmol/L (SD 0.86).  
 
Figure 4: Baseline sample - distribution of cholesterol level 
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Figure 5: Baseline sample – cholesterol levels 
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A desirable level of blood total cholesterol is 5.0 mmol/L or below.  As Table 5 illustrates, 32.5% of 
the baseline sample had a total blood cholesterol level of over 5.0mmol/L.   
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Table 5: Baseline Sample – cholesterol mmol/L 
Cholesterol Level  Number of Participants Percentage of Participants 
5 or below 133  67.5 
Over 5 64 32.5 
Total 197 100 
 
 
A statistically significant difference is found in the percentage of participants having undesirable 
cholesterol levels by age group (X2 =32.44, df= 5, p<0.001).  Figure 6 shows how both those with 
acceptable and high levels of cholesterol are spread in age groups. As expected, a high percentage of 
the older age groups had high levels of cholesterol. 
 
Figure 6: Baseline sample - percentage of participants by age for high and acceptable 
levels of cholesterol 
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A statistically significant association was found between gender and whether or not the cholesterol 
level was above 5 mmol/L (X2 = 4.82, df=1, p=0.028), with a statistically significant higher proportion 
of the males (42.3%) having a cholesterol level above 5 mmol/L compared to the females (26.9%), 
this illustrated in Figure 7. 
 
The mean level of cholesterol for males in London and the South East is 5.21 (SD 1.20) (NDNS 2004).  
The mean total of blood cholesterol for male participants in this study was 4.77 mmol/L (SD 0.88 
mmol/L). This is slightly lower than the regional average but is to be expected as people were 
excluded from the study if they were on cholesterol lowering medication. Similarly, the mean total 
blood cholesterol for the female participants (4.61 mmol/L, SD 0.84 mmol/L) is also lower than the 
regional average which is 5.20; again this is to be expected.   There is no significant difference in the 
mean cholesterol level for males and females (p=0.212). 
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Figure 7: Baseline sample - percentage of participants by cholesterol levels for each 
gender 
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4.2 BMI 
 
Figure 8 shows the distribution of BMI in the baseline sample. The mean BMI is 27.4kg/m2 (SD 5.96 
kg/m2). 
 
Figure 8: Baseline Sample - Histogram showing distribution of BMI 
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A BMI of 25 or over is classed as overweight and a BMI of over 30 of over is classed as obese. The 
majority (60.3%) of the participants were either overweight or obese at baseline.  Levels of CHD are 
highest amongst those people who have a BMI in the obese category.   Table 6 shows the breakdown 
of the participants by BMI category. 
 
Table 6: Baseline sample – BMI category of participants 
BMI Category  No. % 
Underweight Below 20 8 4.0 
Normal 20-25 71 35.7 
Overweight 25-30 70 35.2 
Obese Over 30 50 25.1 
Total  199 100.0 
 
 
Table 7 and Figure 9 illustrate, 68.5% of the males were either overweight or obese compared to 
55.5% of the females. It is estimated that 22% of men and 23% of women in the UK are currently 
obese, and figures from our sample show that 24.7% of men and 25.4% of women were in the obese 
category at baseline, which is higher than the national average. 
 
 
Table 7: BMI by gender – Number at baseline sample 
 Underweight/Normal Overweight/obese Total 
Male 23 50 73 
Female 56 70 126 
 
 
Figure 9: Baseline Sample - participants by BMI category for each gender 
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Compared to the mean BMI for males in the UK which is 27.2 kg/m2, the mean BMI of this male 
sample is slightly higher at 27.49 kg/m2 (SD 4.28 kg/m2).  For women, the mean BMI in the UK is 
lower than the males at 26.4 kg/m2 (NDNS 2004) and our sample of females is also slightly lower than 
the males at 27.38 kg/m2 (SD 6.78 kg/m2) but higher than the national average.   
 
  14
4.3 Smoking  
 
It is estimated that in the UK 26% of people smoke, 25% of women and 27% of men (DOH 2004).  
As Table 8 illustrates, the percentage of smokers in the baseline sample (26.5%) is about the same as 
the national average.  However, the percentage of male smokers in the baseline sample (31.4%) is 
higher than the national average and the percentage of female smokers (22.2%) is lower than the 
national average. 
 
Table 8: Smoking prevalence – baseline sample 
 No. (%) No. (%) Total 
Male smokers 23 (31.5%) 50 (68.5%) 73 (100%) 
Female smokers 28 (22.2) 98 (77.8%) 126 (100%) 
Total 51 (25.6%) 148 (74.4) 199 (100%) 
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5.0 12 WEEK FOLLOW-UP – COMPARISON OF ATTENDERS AND NON-ATTENDERS 
 
Of the 199 people who consented to take part in the study, 111 (56%) returned for their 12 week 
follow-up.   
 
A comparison of the demographic and baseline characteristics of those who decided to attend the 12 
week follow-up and those who did not was conducted to see if there were any statistically significant 
differences between those who returned for follow-up and those who did not.   
 
A chi-squared test (X2 = 5.23, df=1, p=0.022) shows there is an association between gender and 
those who returned for their 12 week follow-up session.  As Table 9 and 10 illustrate the proportion of 
women returning is much greater than the proportion of men, 45.2% of males returned and 61.9% of 
females returned.  At 12 weeks 70.3% of the attendees were women.  The percentage of men 
decreased from 36.7% in the baseline sample to 29.7% of the sample at the 12 week point. 
 
Table 9: 12 week follow-up sample – attendance by gender 
 No. % 
Male 33 29.7 
Female 78 70.3 
Total 111 100.0 
 
 
Table 10: Attendance at baseline and 12 weeks by gender 
 % Male % Female Total  
Those who did not attend at 12 weeks (n=88) 45.5 54.5 100% 
Those who did attend at 12 weeks (n=111) 29.7 70.3 100% 
 
The other factors examined were weight, BMI, blood pressure, physical activity status, stage of 
change, age, ethnicity and smoking status.  No statistically significant differences were found between 
those who attended the follow-up consultation and those who did not.   
 
Table 11 illustrates the percentage of people who attended the 12 week follow-up consultation by 
age.  Although no significant difference was found, it can be seen that the proportion of older people 
returning is greater than the proportion of younger people.  86% of those aged 60 or over returned 
and 48% of those aged up to 29 returned. 
 
Table 11: 12 week follow-up sample - number of those who returned by age 
Age Groups 18-24 25-29 30-44 45-59 60-64 65+ Total 
Did not attend 15 14 36 21 1 1 88 
Attended 13 14 49 22 6 7 111 
 
Table 12 illustrates the number of people who attended the 12 week month follow-up consultation by 
ethnicity.  The proportion of White participants amongst the attendees is 46.3%, lower than the 
proportion of White participants among the non-attendees 55.8% and the proportion of the White 
participants in the baseline sample 50.2%.  The proportion amongst Black attendees at 12 weeks is 
35.2%, higher than the proportion amongst the non-attendees 28.6% at 12 weeks and the proportion 
of Black participants in the baseline sample 32.4%.  The differences were not statistically significant. 
 
Table 12: 12 week follow-up sample - number of those who returned by ethnicity 
Ethnic Groups White Mixed Asian Black Chinese Other Total 
Did not attend 43 4 5 22 1 2 77 
Attended 50 7 8 38 2 3 108 
 
In conclusion, with the exception of gender, the people who returned for the follow-up MOT were 
similar to those who dropped out in terms of other demographic characteristics and values for health-
related variables at baseline.  It is therefore reasonable to suppose that the people who completed 
their 12 week follow-up are representative of the sample originally recruited. 
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6.0 HEALTH STATUS CHANGES BETWEEN BASELINE AND 12 WEEKS 
 
6.1 Cholesterol 
 
12 week and baseline cholesterol values were available for 110 participants.  These results are based 
on those 110 people.  The mean level at baseline was 4.69 mmol/L (SD 0.90 mmol/L) and the mean 
level at 12 weeks was 4.42 mmol/L (SD 0.77 mmol/L).  
 
A paired sample two-tailed t-test was used to analyse change in the mean cholesterol levels between 
baseline and 12 weeks.   A statistically significant difference is found (p<0.001).   
 
There was a reduction in mean cholesterol level of 0.28 mmol/L (SD 0.70 mmol/L), the 95% 
confidence interval for the mean change is 0.15 mmol/L to 0.41 mmol/L.  This is a 5.9% reduction in 
the mean cholesterol mmol/L level over 12 weeks.   
 
Figure 10: Boxplot showing spread of cholesterol mmol/L at baseline and 12 weeks 
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It is clear from the boxplot in Figure 10 that the median cholesterol level has decreased, the median is 
lower at 12 weeks than at the baseline and there is also a smaller spread. However to see how 
individuals have been affected we need to consider individual changes.  
 
Figure 11 shows a boxplot of the changes in cholesterol, a positive value for change indicates an 
improvement since it implies that the 12 week value is lower than the baseline value. Thus, all those 
whose change in cholesterol shows as above zero have improved.  Since the median is above zero this 
shows that more than half have improved their cholesterol, a few (n=18) have improved (reduced 
their cholesterol) by over 1mmol/L. 
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Figure 11: Boxplot showing change in cholesterol mmol/L between baseline and 12 
weeks 
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A desirable level of blood total cholesterol is 5.0 mmol/L or lower (NDNS 2004). As Table 13 illustrates 
there was an increase in the percentage of people who attained a cholesterol level of 5 or below, from 
66.4% at baseline to 80.9% at 12 weeks. 
 
Table 13: Cholesterol, mmol/L, at baseline and 12 weeks 
Baseline Twelve weeks 
Number of participants 
(%) 
Number of participants 
(%) 
5 mmol/L or below 73 (66.4%) 89 (80.9%) 
Over 5 37 (33.6%)  21 (19.1%) 
Total 110 110 
 
As illustrated in Table 14, this was a statistically significant change (p=0.001 using a McNemar Test). 
Table 14 also shows that only 3 of the participants who had a cholesterol level of 5 mmol/L or below 
at baseline had increased their level at 12 weeks, while 18 participants whose cholesterol levels were 
over 5mmol/L at baseline decreased into the desirable range.   
 
Table 14: Comparison of participants’ cholesterol level at baseline and 12 weeks 
  12 week Total 
 5 mmol/L  or Below Over 5 mmol/L  
5 mmol/L or Below 70 3 73 
 
Baseline 
Over 5 mmol/L 19 18 37 
Total  89 21 110 
 
 
6.2 Glucose 
 
12 week and baseline glucose levels were available for 109 participants.  These results are based on 
those 109 participants.  The mean glucose level at baseline was 5.22 mmol/L (SD 1.29 mmol/L) and 
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the mean level at 12 weeks was 4.92 mmol/L (SD 1.09 mmol/L).  
 
A paired sample two-tailed t-test was used to analyse mean change in glucose levels between 
baseline and 12 weeks.  A statistically significant difference is found (p=0.026).   
 
The mean change was 0.30 mmol/L (SD 1.38 mmol/L), the 95% confidence interval for the mean 
change is 0.037 mmol/L to 0.56 mmol/L.  This is a 5.7% reduction in the mean glucose level over 12 
weeks.  
 
Figure 12: Boxplot showing spread of glucose mmol/L at baseline and 12 weeks 
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It is clear from the box plot in Figure 12 that the median glucose level has decreased, the median is 
lower at 12 weeks than at the baseline and there is also a smaller spread. However to see how 
individuals have been affected we need to consider individual changes.  
 
Figure 13 shows a boxplot of the changes in glucose, a positive value for change indicates an 
improvement since it implies that the 12 week value is lower than the baseline value. Thus, all those 
whose change in glucose shows as above zero have improved.   
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Figure 13: Boxplot showing change in glucose mmol/L between baseline and 12 weeks 
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The percentage of participants who attained a glucose level of 6mmol/L or below rose, from 72.5% at 
baseline to 84.4% at 12 weeks.  This is illustrated in Table 15. 
 
Table 15: Glucose levels, mmol/L, at baseline and twelve weeks 
Baseline Twelve weeks 
Number of 
participants (%) 
Number of participants 
(%) 
6 mmol/L or below 79 (72.5%) 92 (84.4%) 
Over 6 mmol/L 30 (27.5%) 17 (15.6%) 
Total 109 109 
 
Table 16 shows this was a statistically significant change (p=0.041 using a McNemar Test). The table 
also shows that 24 participants who had a glucose level of over 6mmol/L at baseline had decreased by 
12 weeks.   
 
 
Table 16: Comparison of participants’ glucose levels at baseline and 12 weeks 
  12 week Total 
 6 mmol/L  or Below Over 6 mmol/L  
6 mmol/L or Below 68 11 79 
 
Baseline 
Over 6 mmol/L 24 6 30 
Total  92 17 109 
 
 
6.3 SF-36 
 
Paired sample t-tests were used to explore the 8 health dimension scores.  Scores on each dimension 
range from 0 to 100, on each dimension a higher number indicates a better state of health.  As Table 
17 illustrates a statistically significant difference (improvement in health) is found in 2 of the 8 
dimensions, ‘bodily pain’ (p=0.017) and ‘general health perception’ (p<0.001). The other 6 
  20
dimensions, showed small but non-significant increases. The full set of dimension scores are detailed 
in Table 17.  
 
Table 17:  SF-36 Dimension Scores – 12 weeks  
  
 
df 
Mean (sd) 
Baseline 
Mean (sd) 
12 weeks 
Mean Change 
(95% Confidence 
interval) 
P-value 
Paired t-
test 
Physical Function 
 
81 86.58 (20.41) 86.10 (22.51) -0.49 (-5.18, 4.20) 0.837 
Role Limitation due to 
Physical Problems 
 
84 82.2 (32.59) 89.41 (25.99) 7.24 (-0.13, 14.60) 0.054 
Role Limitation due to 
Emotional Problems 
92 82.08 (32.06) 86.37 (29.59) 4.30 (-2.66, 11.26) 0.223 
Social Functioning 
 
93 85.70 (21.10) 88.3 (20.9) 2.56 (-2.00, 7.18) 0.266 
Mental Health 
 
94 73.11 (18.58) 75.87 (16.76) 2.77 (-0.23, 5.76) 0.070 
Energy Vitality 
 
97 61.17 (18.4) 63.9 (17.5) 2.8 (-0.27, 5.9) 0.074 
Bodily Pain 98 74.97 
(26.87) 
80.92 (24.07) 5.96 (1.11, 10.81)  0.017 
General Health 
Perception 
95 70.26 
(18.38) 
75.56 (19.05) 5.30 (2.54, 8.06) <0.001 
(items in bold are statistically significant at the 0.05 level) 
 
 
6.4 Food Choices 
 
Participants were asked about their food choices. There were 10 possible items relating to cooking 
and eating.  Participants were asked whether they: rarely, sometimes or always chose to do them 
(see Appendix IV).  Paired sample t-tests were then used to analyse changes in the number of healthy 
and non-healthy food choices participants reported at baseline and 12 weeks.   
 
Healthy Food Choices 
 
Healthy food choice data was available for 103 participants at both time points.  As Table 18 
illustrates 44.7% of participants increased their number of healthy food choices by one or more, 
25.2% remained unchanged and only 8.7% decreased by more than one. The mean number of 
healthy food choices of those who participated was 3.21 at baseline and 3.77 at 12 weeks.  This 
represents a statistically significant change in the mean number of healthy food choices (p=0.003, 
using Wilcoxon Signed Rank Test). 
 
Table 18: Change in number of healthy food choices between baseline and 12 weeks 
 No. of Participants 
Decreased by more than 1 9 
Decreased by 1 22 
No change 26 
Increased by 1 21 
Increased by more than 1 25 
Total 103 
 
Non-healthy Food Choices 
 
Non-healthy food choice data was available for 101 participants at both time points.  As Table 19 
illustrates 40.6 % of participants decreased the number of non-healthy food choices by one or more 
from baseline to 6 months, 47% remained unchanged and only 2% increased their number of non-
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healthy food choices by more than one.  A statistically significant change (decrease) was found in the 
number of people reporting non-healthy food choices (p<0.001, using Wilcoxon Signed Rank Test).  
   
Table 19: Change in number of non-healthy food choices between baseline and 12 weeks 
 No. of Participants 
Decreased by more than 1 14 
Decreased by 1 27 
No change 48 
Increased by 1 10 
Increased by more than 1 2 
Total 101 
 
 
6.5 Stage of Change 
 
‘Stage of Change’ data for both time points was available for 90 of the participants.  A two-tailed sign 
test was used to see if there is a statistically significant difference between the baseline and 6 month 
‘Stage of Change’ responses. The sign test indicated that there was not a statistically significant 
change (p=0.391) with the majority, 45.6% having made no change. 
 
Table 20: Stage of change at 12 weeks 
 Number of Participants Percentage of Participants 
Negative Difference 21 23.3 
Positive Difference 28 31.1 
No change 41 45.6 
Total 90 100 
 
 
 6.6 Seven Day Activity Recall 
 
12 week and baseline seven day activity recall data was available for 60 participants (30.2%). The 
participants were asked about the amount of time (measured in minutes, over the previous seven day 
period) they had spent on different types of physical activity.  The total amount of minutes, 
(categorised into different types of physical activity) is then converted into energy expenditure (in kcal 
per week, for a fuller explanation see Appendix IV).  
 
The mean energy expenditure for the 60 participants at baseline was 2624.30 kcal/week (SD 2000.81 
kcal/week) and at 12 weeks was 3134.11 kcal/week (SD 2544.45 kcal/week).  The mean change (12 
week minus baseline) was 509.81 kcal/week (SD 2391.73 kcal/week), the 95% confidence interval for 
the mean change is -108.04 kcal/week to 1127.66 kcal/week.  The difference in the reported energy 
expenditure between the baseline and 12 week consultations is not statistically significant (p=0.104).  
 
 
6.7 Smoking 
 
Individuals’ smoking habits were compared at baseline and 12 weeks, no statistically significant 
changes were found (p=0.625 using McNemar Test).  Table 21 illustrates the results. 
 
Table 21: Comparison of participants smoking habits at baseline and 12 weeks 
  Smoking status at 12 
weeks 
Total 
  Yes No  
Yes 22 1 23 Smoking status at 
baseline No 3 85 88 
Total  25 86 111 
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 6.8 Lifestyle Changes 
 
At both consultations, participants were asked if they would like to make changes to their lifestyle, 
103 participants responded to this question at both time points. Table 22 shows that 84.5% wanted to 
make changes at baseline and 83.5% at 6 months.   
 
Table 22: Percentage of those who would like to make changes to their lifestyle 
 % at Baseline % at 12 weeks 
Yes 84.5 83.5 
No 15.5 16.5 
Total 100 100 
 
Table 23 illustrates that 75.7% of participants said yes at both time points and 7.8% said no at both 
time points.  The table also shows that 9 participants who initially said yes had changed their mind by 
12 weeks and 8 participants who said no initially had decided by 12 weeks that they should change. 
No statistically significant difference (p=1.00 using McNemar Test) was found. 
 
Table 23: Comparison of the number of participants wanting to make lifestyle changes at 
baseline and 12 weeks 
  12 week Total 
 Yes No  
Yes 78 9 87 
 
Baseline 
No 8 8 16 
Total  87 17 103 
 
 
6.9 Other Tests 
 
Tests carried out to investigate changes in other outcome variables are shown in Table 24.  Weight, 
Body Mass Index, Systolic Blood Pressure and Waist Measurement all show a small but non-significant 
decrease. Resting Heart Rate and Diastolic Blood Pressure have a small but non-significant increase.   
 
Table 24: Other test results at 12 weeks 
 
                                   
df Mean (sd) 
Baseline 
Mean (sd) 
12 weeks 
Mean Change 
(95% Confidence 
interval) 
P-value 
Paired 
t-test 
Resting Heart Rate 107 69.70 (9.96) 70.86(10.75) 1.16 (-0.88, 3.20) 0.263 
Weight 109 76.79 (18.17) 76.37 (17.72) -0.42 (-0.90, 0.07) 0.092 
Body Mass Index          108 27.64 (5.95) 27.51 (5.81) -0.14 (-0.31, 0.03) 0.115 
Blood Pressure Diastolic  110 78.03 (10.50) 78.13 (10.35) 0.10 (-1.32, 1.52) 0.890 
Blood Pressure Systolic 110 124.09 (17.85) 122.67 (16.93) -1.42 (-3.98, 1.14) 0.273 
Waist Measurement 97 89.30 (14.71) 88.51 (14.15) -0.79 (-1.89, 0.30)  0.154 
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7.0 6 MONTH FOLLOW-UP – COMPARISON OF ATTENDERS AND NON-ATTENDERS  
 
Of the 199 people who consented to take part in the study, 35 (17.6%) returned for their 6 month 
follow-up, and 28 (14.1%) participants attended all three time points. 
 
A comparison of the demographic and baseline health characteristics of those who decided to attend 
the 6 month follow-up was conducted to see if there were any statistically significant differences 
between those who returned for follow-up and those who did not. 
 
As Table 25 and 26 illustrate, no association (p=0.273) was found between gender and those who 
returned for the 6 month follow-up session. At baseline, 36.7% of the sample was male. Of those who 
attended the 6 month follow-up 28.6% were male. 
 
Table 25: 6 month follow-up sample - attendance by gender 
 No. % 
Male 10 28.6 
Female 25 71.4 
Total 35 100.0 
 
 
Table 26: Attendance at baseline and 6 months by gender 
 % Male % Female Total  
Those who did not attend at 6 months (n=164) 38.4 61.6 100% 
Those who did attend at 6 months (n=35) 28.6 71.4 100% 
 
Table 27 shows age of the participants who returned at 6 months and those who did not.     
 
Table 27: 6 Month follow-up sample - number of those who returned by age 
Age Groups 18-24 25-34 35-44 45-54 55-64 65+ Total 
Did not attend 26 43 51 24 16 4 164 
Attended 2 7 12 6 4 4 35 
 
A Mann-Whitney test (p=0.017) shows there is a strong association between the age and those who 
returned for their 6 month follow-up session. This suggests that the programme has been more 
successful at retaining the older people. 
 
The other factors examined were, weight, BMI, blood pressure, cholesterol, glucose, stage of change, 
physical activity level and smoking status.  No statistically significant differences were found in the 
baseline values between those who attended the final consultation and those who did not.   
 
Table 28 illustrates the number of people who attended the 6 month follow-up consultation by 
ethnicity. The proportion of White people amongst the attendees is 50.0%, very similar to the 
proportion amongst the non-attendees 50.3% and the proportion of White participants in the baseline 
sample 50.3%.  Similarly, the proportion of Black attendees, at 6 months is 26.5%, similar to the 
proportion amongst the non-attendees 33.8% at 6 months and the proportion of Black participants in 
the baseline sample 32.4%. 
  
Table 28: 6 Month follow-up sample - number of those who returned by ethnicity 
Ethnic Groups  White Mixed Asian Black Chinese Other Total 
Did not attend 76 10 8 51 2 4 151 
Attended 17 1 5 9 1 1 34 
 
In conclusion, with the exception of age, the people who returned for the 6 month follow-up 
consultation were similar to those who dropped out in terms of other demographic characteristics and 
values for health related variables at baseline.  It is therefore reasonable to suppose that, while the 
people who completed their 6 month consultation maybe small in number, they are representative of 
the sample originally recruited. 
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8.0 HEALTH STATUS CHANGES BETWEEN BASELINE AND 6 MONTHS 
 
8.1 Cholesterol 
 
Six-month and baseline cholesterol values were available for 35 participants.  These results are based 
on those 35 people. The mean cholesterol level at baseline was 4.79 mmol/L (SD 0.84 mmol/L) and 
the mean level at 6 months was 4.16 mmol/L (SD 0.60 mmol/L).   
 
A paired sample two-tailed t-test was used to analyse mean change in the cholesterol levels between 
baseline and 6 months.   A statistically significant difference is found (p< 0.001).   
 
The mean change is 0.634 mmol/L (SD 0.93 mmol/L), the 95% confidence interval for the mean 
change is 0.31 mmol/L to 0.95 mmol/L. This represents a 13.2% reduction in the mean cholesterol 
level over the 6 month period. 
 
 
Figure 14: Boxplot showing spread of cholesterol mmol/L at baseline and 6 months 
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It is clear from the boxplot in Figure 14 that the mean cholesterol level has decreased for this group 
as a whole, the median is lower at 6 months than at baseline and there is also a smaller spread.  
However, to see how individuals have been affected we need to consider individual changes. 
 
Figure 15 shows a boxplot of the changes in cholesterol, a positive value in the boxplot indicates an 
improvement since it implies that the 6 month value is lower than the baseline value. Thus, all those 
whose change in cholesterol shows as above zero have improved.  Since the lower quartile is above 
zero this shows that 75% of those who returned at 6 months have improved and 37% have improved 
by over 1mmol/L. 
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Figure 15: Boxplot showing change in cholesterol mmol/L between baseline and 6 
months 
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As Table 29 illustrates, there was an increase in the number of participants who attained a cholesterol 
level of 5 or below, from 22 (62.8%) at baseline to 31 (88.6%) at 6 months. 
 
Table 29: Cholesterol, mmol/L, at baseline and 6 months 
 Baseline 
Number of participants 
(%) 
6 months 
Number of participants 
(%) 
5 mmol/L or below 22 (62.8) 31 (88.6) 
Over 5 mmol/L 13 (37.2) 4 (11.4) 
Total 35 35 
 
As illustrated in Table 30, this is a statistically significant change (p = 0.012) using a McNemar Test, 
with 76.9% of those who were above 5mmol/L at baseline being below 5mmol/L at 6 months. 
 
Table 30: Comparison of participants' cholesterol at baseline and 6 months 
 6  month Total 
 5 mmol/L or below Over 5 mmol/L 
Baseline 5mmol/L or below 21 1 22 
 Over 5 mmol/L 10 3 13 
Total  31 4 35 
 
For the three time points we have cholesterol values available for 28 participants.  Figure 16 illustrates 
the reductions in cholesterol over the 6 month period. 
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Figure 16: Boxplot showing spread of cholesterol mmol/L at baseline, 12 weeks and 6 
months 
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It is clear from the boxplot in Figure 16 that the mean cholesterol level has decreased over the 6 
months for this group as a whole, the median is lower at 12 weeks and then lower again at 6 months. 
At each successive time point the spread gets smaller. The mean level at baseline was 4.82 mmol/L 
(SD 0.84 mmol/L) at 12 weeks was 4.55 mmol/L (SD 0.66 mmol/L) and 6 months was 4.15 mmol/L 
(SD 0.63 mmol/L).   
 
Using analysis of variance to compare the mean level of cholesterol at the three time points indicates 
the means are significantly different (p=0.003).  Exploring pair wise differences with t-tests we find a 
significant reduction between baseline and 12 weeks and a further significant reduction from 12 
weeks to 6 months.  The details of the paired t-test comparisons are as follows.   
 
The mean change between baseline and 12 weeks is 0.27 mmol/L (SD 0.82 mmol/L), the 95% 
confidence interval for the mean change is -0.04.7 mmol/L to 0.59 mmol/L. This represents a 5.6% 
reduction in the mean cholesterol level. A statistically significant difference was not found (p=0.092). 
 
The mean change between 12 weeks and 6 months is 0.40 mmol/L (SD 0.75 mmol/L), the 95% 
confidence interval for the mean change is 0.11 mmol/L to 0.69 mmol/L. This represents an 8.8% 
reduction in the mean cholesterol level and a statistically significant difference (p=0.009). 
 
The mean change between baseline and 6 months is 0.67 mmol/L (SD 0.97 mmol/L), the 95% 
confidence interval for the mean change is 0.30 mmol/L to 1.05mmol/L. This represents a 13.9% 
reduction in the mean cholesterol level for this group over the 6 month period and a statistically 
significant difference (p=0.001).  
 
The t-tests and boxplot (Figure 16) illustrate that the mean cholesterol level has continued to 
decrease with the greatest reduction being in the final 3 months. 
 
 
8.2 Glucose 
 
Six month and baseline glucose levels were available for 23 participants.  These results are based on 
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those 23 participants. The mean glucose level at baseline was 5.07 mmol/L (SD 0.95 mmol/L) and the 
mean level at 6 months was 4.6 mmol/L (SD 2.13 mmol/L). 
 
A paired sample two-tailed t-test was used to analyse mean change in glucose levels between 
baseline and 6 months.  A statistically significant difference was NOT found (p=0.280). 
 
The mean change is 0.47 mmol/L (SD 2.05 mmol/L), the 95% confidence interval for the mean 
change is -0.41 mmol/L to 1.36 mmol/L.  Whilst this represents a 9.3% reduction in the mean glucose 
level over 6 months, it is not a statistically significant change. 
 
Figure 17: Boxplot showing spread of glucose mmol/L at baseline and 6 months 
6 monthsBaseline
G
lu
co
se
 m
m
ol
/L
12
10
8
6
4
2
0
 
 
 
Although the change was not significant it is clear from the boxplot in Figure 17 that the median 
glucose level has decreased, the median is lower at 6 months than at baseline. 
 
Figure 18 shows a boxplot of the changes in glucose, a positive value in the boxplot indicates an 
improvement since it implies that the 6 month value is lower that the baseline value.  Thus, all those 
whose change in glucose shows as above zero have improved. 
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Figure 18: Boxplot showing change in glucose mmol/L between baseline and 6 months 
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The number of participants who attained a glucose level of 6mmol/L or below increased by 1, this is 
illustrated in Table 32. 
 
Table 31: Glucose levels, mmol/L, at baseline and 6 months 
  Baseline 
 Number of Participants
(%) 
6 months 
Number of Participants 
(%) 
6 mmol/L or below 19 (82.6%) 20 (87.0%) 
Over 6 mmol/L 4 (17.4%) 3 (13.0%) 
Total 23 23 
 
 
Table 32: Comparison of participants’ glucose levels at baseline and 6 Months 
  6  Months Total 
6 mmol/L or below Over 6 mmol/L
6 mmol/L or below 17 3 20 Baseline 
 Over 6 mmol/L 2 1 3 
Total 19 4 23 
 
 
8.3 SF-36 
 
Paired sample t-tests were used to explore the 8 health dimension scores.  Scores on each dimension 
range from 0 to 100, on each dimension a higher number indicates a better state of health.  As Table 
33 illustrates a statistically significant difference (improvement in health) is found in 1 of the 8 
dimensions: ‘role limitation due to physical problems’. The full set of dimension scores are detailed in 
Table 33.  
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Table 33: SF-36 Dimension Scores 
  
 
df 
Mean (sd) 
Baseline 
Mean (sd) 
6 months 
Mean Change 
(95% Confidence 
interval) 
P-value 
Paired 
  t-test 
Physical Function 
 23 85.2 (22.1) 82.5 (27.0) -2.71 (-11.06, 5.64) 0.509 
*Role Limitation due 
to Physical Problems 28 75.0 (34.1) 86.2 (28.8) 
11.21 (1.17, 
21.24) 0.030 
Role Limitation due to 
Emotional Problems 29 86.7 (28.5) 83.3 (33.6) -3.34 (-15.28, 8.60) 0.572 
Social Functioning 
 30 86.0 (22.8) 83.2(23.5) -2.86 (-11.08, 5.35) 0.482 
Mental Health 
 30 71.6 (17.4) 74.3 (16.7) 2.71 (-2.56, 7.98) 0.302 
Energy/Vitality 
 31 61.1 (16.6) 62.8 (17.9) 1.71 (-4.12, 7.56) 0.553 
Bodily Pain 
 30 66.7 (29.8) 73.1 (29.8) 6.46 (-2.39, 15.31) 0.147 
General Health 
Perceptions 
 
29 66.3 (19.3) 68.9 (19.7) 2.57 (-3.24, 8.37) 0.374 
 (*item in bold is statistically significant at the 0.05 level) 
 
 
8.4 Food Choices 
 
Participants were asked about their food choices. There were 10 possible items relating to cooking 
and eating.  Participants were asked whether they: rarely, sometimes or always chose to do them 
(see Appendix IV).  Paired sample t-tests were then used to analyse changes in the number of healthy 
and non-healthy food choices participants reported at baseline and 6 months.   
 
8.4.1 Healthy Food Choices 
 
As Table 34 illustrates, 52% of people increased the number of healthy food choices they made, 19% 
remained unchanged, and 19% decreased their number of healthy food choices by more than one. 
The mean number of healthy food choices of those who participated was 3.65 at baseline and 4.26 at 
6 months.  The change in the number of healthy food choices is shown in Figure 19. This does not 
represent a statistically significant change (p=0.230). 
 
Table 34: Change in number of healthy food choices between baseline and 6 months 
 No. of Participants 
Decreased by more than 1 6 
Decreased by 1 3 
No change 6 
Increased by 1 5 
Increased by more than 1 11 
Total 31 
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Figure 19: Change in number of healthy food choices from baseline to 6 months 
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8.4.2 Non-healthy Food Choices 
 
As Table 35 illustrates, 43 % of participants decreased the number of non-healthy food choices they 
made by one or more, 53% remained unchanged, and only 1 person (3.3%) increased by 1 their 
number of non-healthy food choices. The change in number of non-healthy food choices is shown in 
Figure 20 (a positive change represents an improvement – i.e. a decrease in number of non-healthy 
food choices), this distribution is skewed so a non-parametric test is used here. A statistically 
significant change (decrease) was found in the number of non-healthy food choices reported by 
participants (p=0.002 using Wilcoxon Signed Rank Test).  
  
Table 35: Change in number of non-healthy food choices between baseline and 6 months 
 No. of Participants 
Decreased by more than 1 3 
Decreased by 1 10 
No change 16 
Increased by 1 1 
Increased by more than 1 0 
Total 30 
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Figure 20: Change in number of non-healthy food choices from baseline to 6 months 
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8.5 Stage of Change 
 
‘Stage of Change’ data for both time points was available for 25 of the participants.  A two-tailed sign 
test was used to see if there is a statistically significant difference between the baseline and 6 month 
‘Stage of Change’ responses.  The sign test indicated that there is a statistically significant change 
(p=0.007) with 13 participants making positive changes (52.0%) and this is illustrated in Table 36. 
 
Table 36: Stage of Change 
 Number of Participants Percentage of Participants 
Negative Difference 2 8.0 
Positive Difference 13 52.0 
No change 10 40.0 
Total 25 100 
 
 
8.6 Seven Day Activity Recall 
 
Six month and baseline seven day activity data is available for 28 participants, the participants were 
asked about the amount of time (measured in minutes) over the previous seven day period they spent 
on different types of physical activity.  The total amount of minutes, categorised into different types of 
physical activity, is then converted into calorific expenditure (kcal) per week (for a fuller explanation 
see Appendix IV).   
 
The mean amount of calorific expenditure for the 28 participants at baseline was 2271.03 kcal/week 
(SD 1910.36 kcal/week) and the mean amount at 6 months was 3592.92 kcal/week (SD 4822.17 
kcal/week).  The mean change (6 month minus baseline) is 1321.89 kcal/week (SD 5042.99 
kcal/week), the 95% confidence interval for the mean change is -633.58 kcal/week to 3277.36 
kcal/week.  The difference in the reported energy expenditure between the baseline and 6 month 
consultations (p=0.177) is not statistically significant.  
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8.7 Smoking 
 
Individuals’ smoking habits were compared at baseline and 6 months, no statistically significant 
changes were found (p = 1.00 using a McNemar Test).  Table 37 illustrates the results. 
 
Table 37: Comparison of participants smoking habits at baseline and 6 months 
  Smoking status at 6 
Months 
Total 
  Yes No  
Yes 4 1 5 Smoking status at 
baseline  No 1 28 29 
Total  5 29 34 
 
 
8.8 Lifestyle Changes 
 
At both consultations participants were asked if they would like to make changes to their lifestyle.  
Table 38 shows that 28 (80%) participants wanted to make changes at baseline and 27 (77%) at 6 
months, although 5 people who had answered the question at baseline failed to do so at 6 months.  
 
Table 38: Number of those who would like to make changes to their lifestyle 
 Number at Baseline (%) Number at 6 Months (%) 
Yes 28 (80.0%) 27 (77.1%) 
No 7 (20.0%) 3 (8.6%) 
Missing  5 (14.3%) 
Total 35 30 
 
 
Table 39 illustrates that 22 participants said yes at both time points and nobody said no at both time 
points.  No statistically significant difference (p=0.727 using McNemar Test) was found. 
 
Table 39: Comparison of the number of participants wanting to make lifestyle changes at 
baseline and 6 months 
  6 month Total 
 Yes  No  
Yes 22 3 25 
 
Baseline 
No 5 0 5 
Total  27 3 30 
 
 
8.9 Other Tests 
 
Tests carried out to investigate changes in other outcome variables are shown in Table 40.  Weight, 
Body Mass Index (BMI), Waist Measurement, Systolic and Diastolic Blood Pressure all show a small 
but non-significant decrease.  Resting heart rate has a small but non-significant increase.  
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Table 40: Other test results 
 
                                  df Mean (sd) 
Baseline 
Mean (sd) 
6 Months 
Mean Change 
(95% Confidence 
interval) 
P-value 
Paired 
t-test 
Resting Heart Rate 31 71.71 (11.08) 76.53(14.01) 4.81 (-0.47, 10.10) 0.073 
Weight 34 75.09 (22.03) 74.14 (21.69) -0.95 (-2.05, 0.16) 0.090 
Body Mass Index          34 27.92 (7.95) 27.58 (7.82) -0.34 (-0.75, 0.07 0.107 
Blood Pressure Diastolic  34 80.14 (12.89) 77.63 (11.82) -2.51 (-5.71, 0.68) 0.119 
Blood Pressure Systolic 34 126.49 (21.34) 120.57 (20.75) -5.91 (-12.68, 0.85) 0.084 
Waist Measurement 22 88.27 (17.19) 86.87 (15.99) -1.41 (-4.07, 1.25) 0.284 
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9.0 CONCLUSION 
 
The baseline sample consisted of 199 participants recruited into the study at the Healthy Heart MOT 
events in February 2005. The study attracted a larger proportion of women at baseline (63.3%) and a 
lower proportion of older people. 
 
Of the 199 people who consented to take part, 111 (55.8%) returned for their 12 week follow-up, a 
much lower number, 35 (17.6%) returned for their 6 month follow-up.  A total of 28 (14.1%) 
participants attended all three time points. 
 
A comparison of attenders and non-attenders at all three time points found that there is an 
association (p=0.022) between gender and those deciding to return at 12 weeks, 70.3% of those who 
returning were women. At the 6 month follow-up an association (p=0.017) is found between age and 
those deciding to return, the study managed to retain a larger proportion of older people.  No other 
associations at either time point were found. So it is reasonable to assume that the people who 
completed their follow-ups are reasonably representative of the sample originally recruited. 
 
An analysis of the changes in health status at 12 weeks and 6 months found statistically significant 
changes in several outcome variables. 
 
 
Cholesterol 
 
Firstly, in the primary outcome variable, cholesterol, statistically significant changes are found at both 
12 weeks and 6 months in comparison to baseline values.  There was a 14.5% increase at 12 weeks 
and 25.8% increase at 6 months in the number of people attaining a desirable cholesterol level of 
5mmol/L or below. 
 
The was also a statistically significant change in the mean cholesterol levels compared to baseline, 
with a reduction at 12 weeks and 6 months by -0.28mmol/L and -0.634 mmol/L respectively.  This 
represents a 5.9% reduction at 12 weeks that increases to a 13.2% reduction at 6 months.   
 
 
Glucose 
 
There was an 11.9% increase in the number of people who attained a glucose level of 6mmol/L or 
below at 12 weeks.  This was a statistically significant change (p=0.041) with 24 participants who had 
a glucose level of 6mmol/L at baseline decreasing to a desirable level.   
 
The mean glucose level by 12 weeks had decreased by -0.30 mmol/L; this decrease is statistically 
significant.  This is a 5.7% reduction in the mean glucose level over 12 weeks. 
 
No significant changes in glucose level were found at 6 months.  
 
 
SF-36 
 
An analysis of the SF-36 shows statistically significant changes, in the direction of improved health, 
both at 12 weeks and 6 months, on different dimesions.  At 12 weeks 2 of the 8 dimensions showed 
an improvement, ‘bodily pain’ (p=0.017) and ‘general health perception’ (p<0.001).  At 6 months 1 
dimension ‘role limitations due to physical problems’ (p=0.030) showed an improvement. 
 
 
Food Choices 
 
At 12 weeks there was a statistically significant increase (44.7% p=0.003) in the number of healthy 
food choices participants were reporting.  There was also a statistically significant decrease (40.6% 
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p<0.001) in the number of non-healthy food choices participants were reporting.  At six months there 
was no significant change in the number of healthy food choices, but there was still a statistically 
significant decrease (43% p=0.002) in the reported number of non-healthy food choices. 
 
 
Stage of change 
 
At 12 weeks, 31.1% of participants made a positive change, however this was not statistically 
significant.  At 6 months a statistically significant improvement was found (p=0.007) with 52% of 
participants making positive changes. 
 
 
Other outcome variables 
 
No statistically significant differences were found for: resting heart rate, weight, BMI, blood pressure, 
waist measurement, smoking habits, seven-day activity recall or in the participants desire to make 
lifestyle changes. 
 
 
Implications 
 
Overall, for the participants who stayed with the programme, these findings suggest that FFS has had 
a positive and sustained effect on their health. There were significant and lasting changes in the 
participant’s food choices throughout the 6 months and while most of the other results were not 
significant at both time points, there was an overall improvement in many of the outcome variables 
most notably, glucose, improvement in health indicators (SF-36), physical activity levels (7 day activity 
recall, Stage of Change), weight, BMI and waist measurements.  But perhaps most significantly of all, 
FFS had a significant and lasting effect on the participant’s cholesterol levels. It has been shown that 
a sustained 1% decrease in blood total cholesterol produces about a 2-3% decrease in the risk of 
developing CHD (Tang et al. 1998).  So, the 13.2% decrease in cholesterol could be said to translate 
into an overall decrease in the risk of participants developing CHD of between 26.4% and 39.6%. If 
this success can be replicated, then the public health implications for a community seem to be 
noteworthy.  An initiative like Flora Fit Street can thus provide a useful template as the government 
seeks to meet its community health targets. 
 
It is hard to speculate on exactly which elements of FFS were effective, the programme had a high 
profile in the community and, over the course of the year, had been active in promoting healthy 
lifestyles in a variety of ways.  However, the Healthy Heart MOTs were the focal point and did follow a 
behaviour change model that has proved effective in other health interventions.  Some further insights 
will be offered by the findings of the small scale qualitative study that has been undertaken to explore 
factors supporting and hindering uptake and adherence.  These findings are still being analysed and 
will be reported separately.  Further study on the effect of integrating this, and maybe investigating 
the effectiveness of other elements used by FFS is appropriate.  The main challenges that lie ahead 
seem to be around how to interest more men and older people to take part initially and how to 
increase retention levels generally.  
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APPENDIX I: Recruitment 
 
(i) Recruitment of the study is outlined in Figure A1 
 
 
Figure A1: Recruitment for study 
 Baseline measurements and consultation with Health Professional 
 
 
     
     
 Assess suitability versus criteria for inclusion in study  
     
 Include   
    
NO   Consent 
 
Exclude (but can still 
take part in Fit Street 
programme)  
  
YES 
   
  
20 min one-on-one consultation with Registered Dietician (RD) 
20 min one-on-one consultation with fitness professional 
Clapham Park Smoking cessation programme (if smoker) 
 
 
   
 
  
 Baseline measures 
above referral levels 
 Baseline measures 
below referral levels 
 
  
 
   
 GP referral letter and GP 
information letter 
 GP information letter  
   
 
  
  
12 weeks during which time access to all Fit Street activities such as fitness 
classes, reduced price activities, cooking club and access to RD and fitness 
professional through the drop in centre, help line and website 
 
 
 
Inclusion Criteria 
 
• 18 years or over 
• Willingness to take part in the study and agreement to comply with the conditions laid out in 
the Consent form. 
 
Exclusion criteria 
 
• Those with gastrointestinal diseases, severe concomitant diseases, liver or kidney failure 
• Those who are pregnant, trying to become pregnant or breast feeding 
• Those who are currently receiving drug therapy for elevated cholesterol levels or hypertension 
• Those already on special diets prescribed by a health care professional 
• Those for whom changes in diet and lifestyle would in any way be detrimental to their health, 
for example unable to exercise for medical reasons such as joint problems 
• Those taking part in another current or recent research study (recent defined as ending in past 
6 months) 
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APPENDIX II: Activities 
 
 
• Healthy Heart MOTs 
 
• Nutritional advisory Service (monthly) 
 
• Professional Fitness advice (monthly) 
 
• Stress Related workshops 
 
• Cooking Classes 
 
• 5 a-side football 
 
• Power-walking 
 
• Running club 
 
• Yoga 
 
• Tai Chi 
 
• Armchair Aerobics 
 
• Tea Dancing 
 
• High-Life Dancing 
 
• Salsa 
 
• Street Dance 
 
• Line Dancing 
 
• Aerobics 
 
• Boxercise 
 
• Circuit Training 
 
• 50% discount card: Swimming, Cycling, Ice skating. 
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APPENDIX III: Visit Schedule 
 
 
Each participant was in informed of his/her own baseline test results by the team member and given 
appropriate advice depending on the results. 
 
If participants had a total cholesterol level of 6.5mmol/L or above, a BP of 145/90 or above, and/or a 
blood glucose level of 6.9 or above, they will be given a letter to take to their GP.  If the GP then 
prescribes medication, the subject will be excluded from the study. 
   
All participants received lifestyle information and advice covering diet, physical activity and smoking 
cessation. This will included an individual 20 minute consultation with a registered Dietician at 
baseline and a follow up at week 12, opportunities for physical activity at no cost or reduced cost and 
access to smoking cessation support, including free nicotine replacement therapy.  
 
All participants had access to the full programme of activities provided by the Flora Fit Street 
programme in Clapham Park. 
 
Throughout the 12 weeks of the intervention the participants were supported by the Flora Fit Street 
Programme Team (including dietitians, fitness professionals and smoking cessation advisors). 
 
At the end of the intervention, participants were asked to attend an exit MOT.  Repeat measurements 
and questionnaires were completed and participants informed of his/her results by the team member 
and were given the opportunity to discuss them. 
 
Final repeat measurements and questionnaires were administered by community nurses at 
consultation at about 26 weeks after the initial baseline date. 
 
  41
APPENDIX IV: Outcome Measures 
 
 
(i) Seven Day Activity Recall – Calculating Energy Expenditure 
 
At each measurement point, the total time spent on each type of activity is calculated in minutes.  The 
total time spent on each of the different types of activity during the days was then converted in 
calorific expenditure values using the following measurements; 
 
Activity Level Male (kcal/min) Females (kcal/min) 
Light 3.45 2.25 
Moderate 6.2 4.45 
Vigorous 8.2 6.45 
 
The total time spent on each activity was multiplied by these values and the total calorific expenditure 
spent on physical activity each week was used in the analysis. 
 
 
(ii) SF-36 
 
The SF-36 is a short 36-item questionnaire that measures 8 multi-item dimensions; this is also a single 
single that measures perceived health change over the past year.  Dimension scores are calculated by 
summing up the raw scores and then transforming them onto a scale: 0 (poor health) to 100 (good 
health).   
 
Dimension  Low Score High Score 
Physical Functioning Limited a lot in performing 
activities including bathing and 
dressing 
Performs all types of physical 
activities without limitations  
Role Limitations due to physical 
problems 
Problems with work or other 
daily activities as a result of 
physical health 
No problems with work or other 
daily activities due to physical 
health 
Role Limitations due to 
emotional problems 
Problems with work or other 
daily activities as a result of 
emotional problems 
No problems with work or other 
daily activities as a result of 
emotional problems 
Social Functioning Extreme and frequent 
interference with normal social 
activities due to physical or 
emotional problems. 
Performs normal social activities 
without interference due to 
physical or emotional problems 
Bodily Pain Severe pain causing 
interference with work (paid or 
unpaid) 
Low or no levels of pain causing 
little, if any, interference in work 
(paid or unpaid)  
Mental Health Feelings of nervousness and 
depression all of the time 
Feels peaceful, happy and calm 
all of the time 
Energy/Vitality Feels tired and worn down all 
the time 
Feels full of energy all the time 
General Health Perceptions Believe personal health is poor 
and likely to get worse 
Believes personal health is 
excellent 
 
  42
 
(iii) Stage of Change   
 
The transtheoretical model purports that individuals move through stages when changing a behaviour 
pattern. The stages are: precontemplation, contemplation, preparation, action and maintenance. 
Participants are asked to indicate which of the following 6 Statements best described their physical 
activity status at the time of the consultation.   
 
A I am not currently very physically active and I don’t intend to become more active in the next 
six months/ I am too busy right now 
 
B I am not currently very physically active, but I am thinking about increasing the amount of 
activity I take in the next six months 
 
C The amount of activity I take varies: sometimes I am physically active, other times not 
   
D  I am currently physically active on most days, but have only just begun to be so within the 
last six months 
 
E I am currently physically active on most days, and have been so for longer than six months 
  
F A year ago I was physically active on most days, but in the last few months I have been less 
active 
 
By using this instrument it can be established to what extent, if any, participant’s motivation/ 
behaviour patterns regarding exercise have changed.   
 
Difference Change at 3 Months 
Positive Client shifts from: 
 
Stage A to B, C, D or E 
Stage B to C, D, or E 
Stage C to D, E 
Stage D to E 
Stage F to B, C, D or E 
 
Negative Client shifts from: 
 
Stage B to A or F 
Stage C to B, A or F 
Stage D to C, B, A or F 
Stage E to D, C, B or A 
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(iV) Food Choice Items 
 
1. Do you try to reduce the fat in your diet?              
 
2. Do you eat at least 5 portions of fruit and vegetables every day?           
              
3. Do you eat beans and pulses at least once a week?           
4. Do you watch out for the salt content of your food?                   
5. Do your drinks contain sugar? 
                
6. Do you eat pastries, pies, fried food, cakes & biscuits?            
 
7. Do you limit the use of fat (like butter) in cooking and on food? 
 
8. When snacking do you eat crisps and peanuts?      
 
9. When snacking do you eat cakes, biscuits, chocolates and sweets? 
 
10. When snacking do you eat fruit and vegetables?  
   
  
 
 
